Riders · The University of Texas M.D. Anderson Cancer Center · Article III: Agencies of Education

Rare and Aggressive Breast Cancer Research Program

Rider 8 in the 2026-27 Act, page III-239

2028-29 request. The University of Texas M.D. Anderson Cancer Center's request has a row with this rider's number. What that row asks could not be checked, so it is not shown. The agency's request.

Through the session

  1. 2024-25 Act In current law rider 8
  2. Introduced (Senate) Amended rider 7
  3. Introduced (House) Amended rider 7
  4. Senate substitute Unchanged rider 7
  5. House substitute Unchanged rider 7
  6. House passed Unchanged rider 7
  7. Conference Unchanged rider 8
  8. 2026-27 Act Unchanged rider 8

Pick any two steps to compare their wording.

What changed in the text

2024-25 Act → Introduced (House): 3 passages changed.

Rare and Aggressive Breast Cancer Research Program. Of the amounts appropriated above in Strategy D.1.2, Breast Cancer Research Program, $2,000,000 in fiscal year 2024 2026 and $2,000,000 in fiscal year 2025 in 2027 from the General Revenue Fund is for the rare and aggressive breast cancer research program. Its efforts will contribute to improving the diagnostics in patients with breast cancer.

Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 8 First version — Page III-213
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) 7 was 8 Amended — Page III-210
Introduced (House)House Bill 1 as introduced (LBB recommended, House) 7 was 8 Amended — Page III-209
Senate substituteCommittee Substitute for Senate Bill 1 7 Unchanged Amended Page III-199
House substituteHouse Committee Substitute for Senate Bill 1 7 Unchanged Amended Page III-202
House passedSenate Bill 1 as passed the second house 7 Unchanged Amended Page III-202
ConferenceConference Committee Report for Senate Bill 1 8 was 7 Unchanged Amended Page III-215
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 8 Unchanged Amended Page III-239
Full text of each wording

Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act

Source, page III-239

Rare and Aggressive Breast Cancer Research Program. Of the amounts appropriated above in Strategy D.1.2, Breast Cancer Research Program, $2,000,000 in fiscal year 2026 and $2,000,000 in fiscal year 2027 from the General Revenue Fund is for the rare and aggressive breast cancer research program. Its efforts will contribute to improving the diagnostics in patients with breast cancer.

2024-25 Act

Source, page III-213

Rare and Aggressive Breast Cancer Research Program. Of the amounts appropriated above in Strategy D.1.2, Breast Cancer Research Program, $2,000,000 in fiscal year 2024 and $2,000,000 in fiscal year 2025 in General Revenue is for the rare and aggressive breast cancer research program. Its efforts will contribute to improving the diagnostics in patients with breast cancer.